Efforts to Define the Natural History of Chronic Hepatitis C Continue

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 10, 2006, Pages 1190-1192

  Ghany, Marc G ^a   Seeff, Leonard B ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; DISEASE SEVERITY; DRUG USE; EDITORIAL; HEPATITIS C; HUMAN; INFECTION RATE; LIVER BIOPSY; LIVER FIBROSIS;

BIOPSY; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 33749429823     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.07.024     Document Type: Editorial

References (22)

1. Mattsson L., Sonnerborg A., and Weiland O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers. Liver 13 (1993) 274-278
2. Hopf U., Moller B., Kuther D., et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 10 (1990) 69-76
3. Di Bisceglie A.M., Goodman Z.D., Ishak K.G., et al. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14 (1991) 969-974
4. Tremolada F., Casarin C., Alberti A., et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 16 (1992) 273-281
5. Koretz R.L., Abbey H., Coleman E., et al. Non-A, non-B post-transfusion hepatitis: looking back in the second decade. Ann Intern Med 119 (1993) 110-115
6. Rai R., Wilson L.E., Astemborski J., et al. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology 35 (2002) 1247-1255
7. Kiyosawa K., Sodeyama T., Tanaka E., et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12 (1990) 671-675
8. Tong M.J., el-Farra N.S., Reikes A.R., et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332 (1995) 1463-1466
9. Yano M., Kumada H., Kage M., et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 23 (1996) 1334-1340
10. Niederau C., Lange S., Heintges T., et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28 (1998) 1687-1695
11. Thomas D.L., Astemborski J., Rai R.M., et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284 (2000) 450-456
12. Kenny-Walsh E., and Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 340 (1999) 1228-1233
13. Wiese M., Berr F., Lafrenz M., et al. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32 (2000) 91-96
14. Poynard T., Bedossa P., Opolon P., OBSVIRC, METAVIR, CLINIVIR, and and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349 (1997) 825-832
15. Wiley T.E., McCarthy M., Breidi L., et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28 (1998) 805-809
16. Benhamou Y., Bochet M., Di Martino V., et al., Multivirc Group. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30 (1999) 1054-1058
17. Bissell D.M. Sex and hepatic fibrosis. Hepatology 29 (1999) 988-989
18. Hourigan L.F., Macdonald G.A., Purdie D., et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29 (1999) 1215-1219
19. Sobesky R., Mathurin P., Charlotte F., et al., Multivirc Group. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 116 (1999) 378-386
20. Levine R.A., Ploutz-Snyder R., Murray F., et al. Lack of fibrosis progression in untreated, noncirrhotic, persistently viremic Irish women with chronic hepatitis C contracted from immunoglobulin Anti-D. Clin Gastroenterol Hepatol 4 (2006) 1271-1277
21. Wiese M., Grungreiff K., Guthoff W., et al. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany: a 25-year multicenter study. J Hepatol 43 (2005) 590-598
22. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54